¼¿ï¾Æ»êº´¿ø Á¦31Â÷ ´ëÇÑÅõ¼®Ç÷°üÇÐȸ Çмú´ëȸ ¹× Á¤±âÃÑȸ : 2019-02-17±³À°ÀÏÀÚ : 2019-02-17
±³À°Àå¼Ò : ¼¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ ´ë°´ç ¹× ¼Ò°´ç
±³À°ÁÖÁ¦ :
Á¦31Â÷ ´ëÇÑÅõ¼®Ç÷°üÇÐȸ Çмú´ëȸ ¹× Á¤±âÃÑȸÁÖÃÖ±â°ü : ´ëÇÑÅõ¼®Ç÷°üÇÐȸ(2017.11.11 ¸íĪº¯°æ)(ÀÎ)
´ã´çÀÚ : ÀÌÁøÇü
¿¬¶ôó : 02-6959-5066
À̸ÞÀÏ :
ksda@aone-a.com ±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¿µ»óÀÇÇаú
Âü¼®¿¹»óÀοø : 600¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 6 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 60,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 02-17 µ¿°ü6Ãþ ´ë°´ç 09:00~09:15 Open and hybrid debulking procedure ¹ÚÇü¼·(¼¿ïÀÇ´ë ¿Ü°ú)
±³À°½Ã°£ 02-17 µ¿°ü6Ãþ ´ë°´ç 09:15~09:30 Open mechanical debulking procedure ±èµµ±Õ(±èµµ±ÕÇ÷°ü¿Ü°ú ¿Ü°ú)
±³À°½Ã°£ 02-17 µ¿°ü6Ãþ ´ë°´ç 09:30~09:45 Rheolytic thrombectomy with Angiojet system ±è¹ÌÁø(ÀüÁÖ¿¹¼öº´¿ø ¿Ü°ú)
±³À°½Ã°£ 02-17 µ¿°ü6Ãþ ´ë°´ç 09:45~10:00 Characteristics of repeated interventions on failed arteriovenous graft and factors affecting patency ±èÇâ°æ(Áß¾ÓÀÇ´ë ¿Ü°ú)
ÈÞ½Ä 02-17 µ¿°ü6Ãþ ´ë°´ç 10:00~10:10 Coffee break ()
±³À°½Ã°£ 02-17 µ¿°ü6Ãþ ´ë°´ç 10:10~10:40 Current status in dialysis access in Japan : brachial artery superficialization has been used as the fourth option Masaaki Murakami(Nephrologist, Intervention, Shizuoka Prefecture Hospital)
±³À°½Ã°£ 02-17 µ¿°ü6Ãþ ´ë°´ç 10:40~11:10 Team approach and training program in dialysis access in Japan Toshihide Naganuma(Urology, Vascular surgery, Osaka City University)
ÈÞ½Ä 02-17 µ¿°ü6Ãþ ´ë°´ç 11:10~11:20 Coffee break ()
±³À°½Ã°£ 02-17 µ¿°ü6Ãþ ´ë°´ç 11:20~11:35 The safety and efficacy of drug-coated balloons (DCB) for access stenosis ¹Ú±Ù¸í(ÀÎÇÏÀÇ´ë ¿Ü°ú)
±³À°½Ã°£ 02-17 µ¿°ü6Ãþ ´ë°´ç 11:35~11:50 Balloon angioplasty with selective stenting strategy ¾öÁØ¿µ(Ãæ³²ÀÇ´ë ¿µ»óÀÇÇаú)
±³À°½Ã°£ 02-17 µ¿°ü6Ãþ ´ë°´ç 11:50~12:05 The role of covered stent ¾È»óÇö(¼¿ïÀÇ´ë ¿Ü°ú)
±³À°½Ã°£ 02-17 µ¿°ü6Ãþ ´ë°´ç 12:05~12:20 Focal force balloon plus drug-coated balloons (DCB) strategy ±è¿ëÀç(¼øõÇâÀÇ´ë ¿µ»óÀÇÇаú)
½Ä»ç 02-17 µ¿°ü6Ãþ ´ë°´ç 12:20~13:30 Lunch ()
±³À°½Ã°£ 02-17 µ¿°ü6Ãþ ´ë°´ç 13:30~13:45 µ¿Á¤¸Æ·çÀÇ ´Ü°èÀû »ç¿ë¹ý À̱ͳà(°¸ª¾Æ»êº´¿ø Àΰø½ÅÀå½Ç)
±³À°½Ã°£ 02-17 µ¿°ü6Ãþ ´ë°´ç 13:45~14:00 Ç÷¾×Åõ¼® Ä«Å×ÅÍÀÇ ¾ÈÀüÇÑ °ü¸®¹æ¹ý ±èÀ±¼ö(ÀÌ´ë¸ñµ¿º´¿ø Àΰø½ÅÀå¼¾ÅÍ)
±³À°½Ã°£ 02-17 µ¿°ü6Ãþ ´ë°´ç 14:00~14:15 PTA ½ÃÇàȯÀÚÀÇ Ç÷°üõÀÚ ½Ã ÁÖÀÇ»çÇ× ¹ÚÆòÁÖ(ÇѸ²´ëÇб³ ¼º½Éº´¿ø Åõ¼®Ç÷°üŬ¸®´Ð)
±³À°½Ã°£ 02-17 µ¿°ü6Ãþ ´ë°´ç 14:15~14:30 ÀϺ»ÀÇ Ç÷¾×Åõ¼® ¹× Ç÷°üÅë·Î °ü¸®½Ã½ºÅÛ ¼Ò°³ Á¤´Ù¿î(°ºÏ»ï¼ºº´¿ø Àΰø½ÅÀå½Ç)
ÈÞ½Ä 02-17 µ¿°ü6Ãþ ´ë°´ç 14:30~14:40 Coffee break ()
±³À°½Ã°£ 02-17 µ¿°ü6Ãþ ´ë°´ç 14:40~15:00 Prevention and management of encapsulating peritoneal sclerosis (EPS) µµÁØ¿µ(¿µ³²ÀÇ´ë ½ÅÀå³»°ú)
±³À°½Ã°£ 02-17 µ¿°ü6Ãþ ´ë°´ç 15:00~15:20 Indication and management of bimodal (PD+HD) treatment ±èÅÂÈñ(ÀÎÁ¦ÀÇ´ë ½ÅÀå³»°ú)
±³À°½Ã°£ 02-17 µ¿°ü6Ãþ ´ë°´ç 15:20~15:40 What¡¯s new in the telehealth and remote monitoring? ÀÌ¿µ±â(ÇѸ²ÀÇ´ë ½ÅÀå³»°ú)
ÈÞ½Ä 02-17 µ¿°ü6Ãþ ´ë°´ç 15:40~15:50 Coffee break ()
±³À°½Ã°£ 02-17 µ¿°ü6Ãþ ´ë°´ç 15:50~16:00 Case 1 ±è¹Î¿í(ÀÌÈÀÇ´ë ¿µ»óÀÇÇаú)
±³À°½Ã°£ 02-17 µ¿°ü6Ãþ ´ë°´ç 16:00~16:10 Case 2 ±Ç¿äÇÑ(¾ÆÁÖÀÇ´ë ¿µ»óÀÇÇаú)
±³À°½Ã°£ 02-17 µ¿°ü6Ãþ ´ë°´ç 16:10~16:20 Case 3 ¹Ú°üÅÂ(¸ù°ñ±¹¸³ÀÇ°ú´ëÇÐ ¿Ü°ú)
±³À°½Ã°£ 02-17 µ¿°ü6Ãþ ´ë°´ç 16:20~16:30 Case 4 ÇÑ¿µÁø(¿ï»êÀÇ´ë ¿Ü°ú)
±³À°½Ã°£ 02-17 µ¿°ü6Ãþ ´ë°´ç 16:30~16:40 Case 5 ÀÌÁøÈ£(ºÀ»ýº´¿ø ½ÅÀå³»°ú)
±³À°½Ã°£ 02-17 µ¿°ü6Ãþ ´ë°´ç 16:40~16:50 Case 6 ÀÌÇü¼®(ÇѸ²ÀÇ´ë ½ÅÀå³»°ú)
±³À°½Ã°£ 02-17 µ¿°ü6Ãþ ´ë°´ç 16:50~17:00 Case 7 ±èÀ¯¿Á(¼øõÇâ´ëÇб³ ¼¿ïº´¿ø Àΰø½ÅÀå½Ç)
±³À°½Ã°£ 02-17 µ¿°ü6Ãþ ´ë°´ç 17:00~17:10 Case 8 ¾ç½ÂºÎ(¼øõÇâÀÇ´ë ¿µ»óÀÇÇаú)
±³À°½Ã°£ 02-17 µ¿°ü6Ãþ ´ë°´ç 17:10~17:20 Case 9 Yang Yongjiu(Beijing ChuiYangLiu Hospital affiliated Tsinghua University, Beijing, China)